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ORIGINAL ARTICLE
Mutations in the CDSN gene cause peeling skin disease and
hypotrichosis simplex of the scalp
Jaap J. A. J.van der VELDEN,1,2 Michelvan GEEL,1,2 Jans J. ENGELHART,3
Marcel F. JONKMAN,4,† Peter M. STEIJLEN1,2
1Department of Dermatology, 2GROW Research School for Oncology and Developmental Biology, Maastricht University Medical
Center+, Maastricht, 3Department of Dermatology, Ommelander Ziekenhuis Groep, Delfzijl, 4Department of Dermatology, University
of Groningen, University Medical Center Groningen, Groningen, The Netherlands
ABSTRACT
Peeling skin disease is a rare genodermatosis characterized by superficial exfoliation or peeling of the skin.
Peeling skin disease is caused by biallelic mutations in CDSN as an autosomal recessive trait. Monoallelic
mutations in CDSN have also been described in an autosomal dominant inherited genodermatosis: hypotrichosis
simplex of the scalp. This disease is characterized by progressive hair loss of the scalp with onset after early
childhood. Clinical data were obtained from a patient with lifelong generalized skin peeling and both his parents.
The patient’s parents did not suffer from skin peeling, but the mother had a history of thin scalp hair since early
childhood. Mutation analysis in the patient showed compound heterozygous mutations in exon 2 of CDSN, a non-
sense mutation c.598C>T (p.[Gln200*]), previously associated with hypotrichosis simplex of the scalp, and a
frame-shift mutation c.164_167dup (p.[Thr57Profs*6]), previously described in peeling skin disease. The p.(Gln200*)
mutation was also found in the mother of the proband. Our study strengthens the previously established link
between mutations in CDSN to peeling skin disease and hypotrichosis simplex of the scalp.
Key words: corneodesmosin, genetic, hypotrichosis simplex of the scalp, peeling skin disease, skin diseases.
INTRODUCTION
Peeling skin syndrome (PSS) was first described by Fox in
1921.1 PSS is a rare autosomal recessive genodermatosis
characterized by superficial exfoliation or peeling of the skin. It
is classified into localized and generalized forms. Acral peeling
skin syndrome (APSS; PSS2; Mendelian Inheritance in Man
[MIM] #609796) is considered a localized variant of PSS and is
caused by mutations in TGM5 encoding transglutaminase 5
(TGM5).2 The generalized form is subclassified into non-inflam-
matory (type A) (PSS3; MIM #616265) and inflammatory (type
B) forms (PSD; PSS1; MIM #270300).3 PSS type A is linked to
mutations in CHST8.4 Recently, mutations in FLG2 were
described in patients with generalized skin peeling.5,6
In PSS type B, also referred to as peeling skin disease
(PSD), mutations in CDSN7–13 and large deletions encompass-
ing CDSN14 have been described. Corneodesmosin (CDSN) is
expressed in hair follicles and cornified epithelia and is consid-
ered to play an important role in cell–cell adhesion.15 PSD is
characterized by congenital ichthyosiform erythroderma with
recurrent superficial exfoliation or peeling of the skin. It is
accompanied by pruritus and (other) atopic manifestations,
mostly accompanied by high levels of immunoglobulin (Ig)E.16
Histological and ultrastructural analyses demonstrate that
cleavage occurs immediately above the stratum granulosum or
within the stratum corneum with overlying compact or basket
weave hyperkeratosis.7 We report a case of PSD caused by
compound heterozygous mutations in CDSN.
METHODS
All the studies described were conducted in accordance with
the Declaration of Helsinki with ethical approval and informed
consent.
Patient
A 19-year-old man visited our outpatient clinic in 2011. From
the age of 2 years, he had visited multiple dermatologists in
other clinics. He suffered from pruritic sub-erythroderma with
extensive skin peeling and scaling since birth (Fig. 1). The con-
dition tended to be worse in winter. He had complaints of ato-
pic dermatitis and hay fever. Hair, teeth and nails appeared
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normal. Routine laboratory parameters were normal, except for
elevated IgE levels (2222 kU/L; normal, <100). Hair shaft analy-
sis did not show trichorrhexis invaginata. As the phenotype
resembled Netherton syndrome, mutation analysis of SPINK5
was performed: no pathogenic mutations were detected. Over
the years, the patient was treated with topical moisturizing
agents, local corticosteroids and a prolonged course of low-
dose isotretinoin; only the latter improved complaints slightly
according to the patient.
His non-consanguineous parents of Lithuanian and Russian
Jewish descent did not show any skin symptoms. Initially, the
proband stated that his parents had no history of obvious hair
loss. After obtaining the results of the mutation analysis, the
mother was assessed in our outpatient clinic. The mother had
a lifelong history of thin scalp hair, gradually worsening as she
aged. Upon examination, the diagnosis hypotrichosis simplex
of the scalp (HSS) was made (Fig. 2). According to the mother,
her twin brother and his son and her father shared the same
hair phenotype (Fig. 3).
Skin tissue analysis
Histopathology (hematoxylin–eosin staining) of a skin biopsy
showed compact hyperkeratosis with focal parakeratosis and
acanthosis with basal separation in the stratum corneum and a
subepidermal lymphocytic perivascular infiltrate.
Electron microscopy showed granular/fibrillar degeneration
of the upper corneocytes with intact cell membranes.
Intracorneal cleavage with intercellular deposition of fibrillar
material was seen. Corneodesmosomes appeared normal. Nor-
mal keratohyalin granules were observed in the stratum granu-
losum. In the papillary dermis, multiple round amorphic
amyloid bodies were seen (Supporting information).
Mutation analysis
Genomic DNA from the affected individual and parents was
isolated from peripheral blood leukocytes using the QIAampTM
blood kit (Qiagen, Hilden, Germany). The two coding exons
and adjacent splice sites of CDSN were amplified by poly-
merase chain reaction using primers as previously described.7
Automated DNA sequencing analysis was performed on an ABI
Prism 3730 genetic analyzer (Applied Biosystems, Foster City,
CA, USA).
RESULTS
Mutation analysis in our patient showed two heterozygous
mutations in exon 2 of CDSN, designated c.598C>T and
c.164_167dup (NCBI reference sequence: NM_001264.4). The
mother was heterozygous for the c.598C>T mutation, whereas
the father was heterozygous for the c.164_167dup mutation
(Supporting information).
The c.598C>T mutation putatively results in a premature
stop codon p.(Gln200*) in the corneodesmosin protein. This
mutation was previously described in patients with HSS (MIM
#146520).17 Amyloid aggregates of mutated corneodesmosin
are found in hair follicles of these patients.18
The c.164_167dup mutation was previously described in
patients with PSD and predicts a frame-shift followed by a stop,
p.(Thr57Profs*6).10 In patients with this mutation, pathogenicity
was demonstrated by the absence of corneodesmosin expres-
sion in the granular layers in skin biopsies.10
DISCUSSION
The link between PSD and corneodesmosin is well established.
Multiple pathogenic mutations of CDSN (Fig. 4) have been
described.7–13 These mutations are homozygous or compound
heterozygous as the mode of inheritance is autosomal reces-
sive. Large homozygous deletions of 59 kb in the 6p21.3
region encompassing CDSN are reported in Japanese patients.
Although the deletion encompasses several other genes
(C6orf15, PSORS1C1, PSORS1C2, CCHCR1 and part of
TCF19), these patients show a phenotype resembling that of
PSD without hypotrichosis.14
Mutations in CDSN have also been described in HSS.17,19–
21 HSS is a rare autosomal dominant genodermatosis charac-
terized by progressive loss of scalp hair. Patients with the
heterozygous nonsense mutations p.(Gln200*), p.(Gln209*),
p.(Gln215*) and p.(Tyr239*) show hypotrichosis; however, a
PSD phenotype is not observed. It is hypothesized that aggre-
gation of truncated CDSN protein into amyloid structures
exerts a toxic effect on the hair follicles of the scalp. The
absence of a PSD phenotype in these patients could be attrib-
uted to the presence of a normal allele and wild-type protein.18
(a)
(b)
Figure 1. Index patient with generalized superficial skin exfoli-
ation/blistering with partly erythematous background. (a) Over-
view, (b) detail.
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Only mutations in the region of amino acids 200–239 lead to
hair loss. Caubet et al.18 have shown that truncated mutants of
CDSN which bear the Gly/Ser-rich domain (GS domain) abnor-
mally accumulate at the periphery of hair follicles. They assem-
ble into non-toxic fibrils and toxic ring-shaped oligomeric
structures. The c.164_167dup mutation in the father resulted in
a relatively small peptide lacking the GS domain which
consequently did not assemble into the oligomeric form and
therefore no hair loss was observed.
The toxic effect of the amyloid aggregates was likely occur-
ring in a dominant negative manner with wild-type and trun-
cated mutant corneodesmosin polypeptides. If the mutation
occurs in the region of amino acids 200–239, a toxic ring-
shaped oligomer is formed in the presence of wild-type
(a) (b)
Figure 2. Mother of the index patient showed diminished hair density on the scalp. (a) Dorsal view, (b) side view.
Figure 3. Family pedigree. The filled symbol depicts the proband with skin peeling and without hypotrichosis; the partially filled
symbols depict subjects with hypotrichosis, birth year displayed underneath the symbols if known.
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corneodesmosin; otherwise, a non-toxic fibrillar structure is
formed. It is likely wild-type corneodesmosin acts as a modify-
ing factor. One could hypothesize that oligomers are formed
by linking truncated mutants to any form of corneodesmosin
bearing the GS domain: truncated polypeptides or wild-type
protein.
The absence of wild-type protein could explain why no hair
phenotype was observed in the 19-year-old patient, although
he carried a mutation in the 200–239 region. Interestingly, skin
biopsies showed amyloid bodies in the papillary dermis of the
patient. It is possible that these bodies only consisted of the
fibrillar aggregates. However, there was no functional data to
confirm this assumption.
Affected HSS individuals have normal hair in early childhood
but experience progressive loss of scalp hair beginning in the
middle of the first decade and almost complete baldness by
the third decade. The body hair, beard, eyebrows, axillary hair,
teeth and nails are normal.17 The severity of the hypotrichosis
is variable. Almost complete loss of scalp hair is described in
patients with the p.(Gln200*) mutation. However, the mother of
the proband, also bearing this mutation, showed hypotrichosis
but was not completely bald. This suggests incomplete or
reduced penetrance of this mutation. This suggestion is sup-
ported by the notion that CDSN is extremely polymorphic22
and the different polymorphic alleles may modify disease pene-
trance.
We believe the diagnosis of HSS is underreported. The rela-
tively mild hair loss in the mother of the proband never led to
the diagnosis of HSS before. The diagnosis was only made
after the mutation in CDSN was found. This exemplifies the
importance of careful assessment (including family history-tak-
ing) of patients with relatively mild hypotrichosis. In these
patients, mutation analysis of CDSN should be considered.
In this study, we emphasized the role of corneodesmosin in
PSD and HSS. Functional corneodesmosin plays an important
role in maintaining the integrity of the epidermal barrier.
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SUPPORTING INFORMATION
Additional Supporting Information may be found in the online
version of this article:
Figure S1. Sequence chromatographs showing the mutations
in exon 2 of CDSN, designated c.598C>T and c.164_167dup in
the patient, father and mother.
Figure S2. Histopathology (hematoxylin–eosin staining) of a
skin biopsy showing amyloid deposits in the papillary dermis.
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